Go Pro
NASDAQ:STAA

STAAR Surgical (STAA) Stock Price, News & Analysis

STAAR Surgical logo
$23.97 -2.47 (-9.34%)
Closing price 04:00 PM Eastern
Extended Trading
$23.61 -0.36 (-1.50%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About STAAR Surgical Stock (NASDAQ:STAA)

Advanced

Key Stats

Today's Range
$23.10
$26.35
50-Day Range
$23.97
$33.34
52-Week Range
$15.59
$35.87
Volume
2.90 million shs
Average Volume
718,728 shs
Market Capitalization
$1.19 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$27.81
Consensus Rating
Hold

Company Overview

STAAR Surgical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
60th Percentile Overall Score

STAA MarketRank™: 

STAAR Surgical scored higher than 60% of companies evaluated by MarketBeat, and ranked 559th out of 840 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    STAAR Surgical has received a consensus rating of Hold. The company's average rating score is 2.09, and is based on no strong buy ratings, 3 buy ratings, 6 hold ratings, and 2 sell ratings.

  • Upside Potential

    STAAR Surgical has a consensus price target of $27.81, representing about 16.0% upside from its current price of $23.97.

  • Amount of Analyst Coverage

    STAAR Surgical has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about STAAR Surgical's stock forecast and price target.
  • Earnings Growth

    Earnings for STAAR Surgical are expected to grow by 130.77% in the coming year, from $0.13 to $0.30 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of STAAR Surgical is -55.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of STAAR Surgical is -55.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    STAAR Surgical has a P/B Ratio of 3.46. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about STAAR Surgical's valuation and earnings.
  • Percentage of Shares Shorted

    17.65% of the float of STAAR Surgical has been sold short.
  • Short Interest Ratio / Days to Cover

    STAAR Surgical has a short interest ratio ("days to cover") of 7.72.
  • Change versus previous month

    Short interest in STAAR Surgical has recently increased by 4.53%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    STAAR Surgical does not currently pay a dividend.

  • Dividend Growth

    STAAR Surgical does not have a long track record of dividend growth.

  • News Sentiment

    STAAR Surgical has a news sentiment score of 0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.67 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for STAAR Surgical this week, compared to 6 articles on an average week.
  • Search Interest

    4 people have searched for STAA on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added STAAR Surgical to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, STAAR Surgical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    39.90% of the stock of STAAR Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    96.70% of the stock of STAAR Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about STAAR Surgical's insider trading history.
Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

STAA Stock News Headlines

STAAR Surgical's (STAA) Outperform Rating Reiterated at Wedbush
Staar Surgical Shares Slide Following Preliminary 2Q Sales
Do this before December or regret it
Porter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December.tc pixel
STAAR drops despite early Q2 beat amid concerns over outlook
STAAR Surgical's Punishment For Opacity Is Just
See More Headlines

STAA Stock Analysis - Frequently Asked Questions

STAAR Surgical's stock was trading at $23.09 on January 1st, 2026. Since then, STAA shares have increased by 3.8% and is now trading at $23.97.

STAAR Surgical Company (NASDAQ:STAA) announced its quarterly earnings data on Wednesday, May, 13th. The medical instruments supplier reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.05. The business's revenue for the quarter was up 119.6% on a year-over-year basis.
Read the conference call transcript
.

STAAR Surgical's Board of Directors approved a stock buyback plan on Friday, May 16th 2025, which permits the company to buy back $30,000,000 in shares, according to EventVestor. This means that the company could buy up to 3.2% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's leadership believes its stock is undervalued.

STAAR Surgical subsidiaries include Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.

Top institutional shareholders of STAAR Surgical include Defender Capital LLC. (0.87%). Insiders that own company stock include Broadwood Partners, LP, Aimee S Weisner, Arthur C Butcher and Elizabeth Yeu Lin.
View institutional ownership trends
.

Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that STAAR Surgical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Palo Alto Networks (PANW) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
5/13/2026
Today
7/20/2026
Next Earnings (Estimated)
8/12/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:STAA
CIK
718937
Employees
1,211
Year Founded
1982

Price Target and Rating

High Price Target
$40.00
Low Price Target
$13.00
Potential Upside/Downside
+16.0%
Consensus Rating
Hold
Rating Score (0-4)
2.09
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.43)
Trailing P/E Ratio
N/A
Forward P/E Ratio
184.38
P/E Growth
N/A
Net Income
-$80.45 million
Net Margins
-7.24%
Pretax Margin
-6.74%
Return on Equity
3.31%
Return on Assets
2.55%

Debt

Debt-to-Equity Ratio
0.09
Current Ratio
5.12
Quick Ratio
4.31

Sales & Book Value

Annual Sales
$239.44 million
Price / Sales
4.98
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.92 per share
Price / Book
3.46

Miscellaneous

Outstanding Shares
49,790,000
Free Float
29,923,000
Market Cap
$1.19 billion
Optionable
Optionable
Beta
1.23

Social Links

10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:STAA) was last updated on 7/20/2026 by MarketBeat.com Staff.
From Our Partners